Ligand Pharmaceuticals (LGND) EV to FCF (2012 - 2026)
Ligand Pharmaceuticals' (LGND) EV to FCF was 37.58 for Q2 2026, up 5.2% from 35.71 a year earlier and up 43.6% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EV to FCF (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' EV to FCF came in at 21.01, down 9.6% year-over-year; for FY2025, it came in at 61.45, down 24.4% from FY2024.
- By year, EV to FCF came in at 81.24 in FY2024 (+245.3%), 23.53 in FY2023 (+206.5%), 7.68 in FY2022 (-57.8%) and 18.20 in FY2021 (+55.6%).
- Five-year quarterly EV to FCF spans a low of 7.68 in Q4 2022 and a high of 1354.61 in Q3 2024.
- Year over year, EV to FCF gained in two of the last four quarters, with growth averaging 33.2%.
- The high point for year-over-year EV to FCF in five years was Q3 2021 (growth of 616.9%); the low point was Q3 2025 (a decline of 93.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 26.17 (Q1 2026), 61.45 (Q4 2025) and 89.52 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.58 |
| Mar 31, 2026 | 26.17 |
| Dec 31, 2025 | 61.45 |
| Sep 30, 2025 | 89.52 |
| Jun 30, 2025 | 35.71 |
| Dec 31, 2024 | 81.24 |
| Sep 30, 2024 | 1,354.61 |
| Mar 31, 2024 | 30.16 |
| Dec 31, 2023 | 23.53 |
| Sep 30, 2023 | 9.51 |
| Jun 30, 2023 | 10.45 |
| Mar 31, 2023 | 9.37 |
| Dec 31, 2022 | 7.68 |
| Sep 30, 2022 | 8.36 |
| Jun 30, 2022 | 8.24 |
| Mar 31, 2022 | 8.92 |
| Dec 31, 2021 | 18.20 |
| Sep 30, 2021 | 25.95 |
| Jun 30, 2021 | 29.57 |
| Mar 31, 2021 | 30.10 |
API Access
Ligand Pharmaceuticals EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();